Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CANTARGIA AB | 71,000 | net | 20 Dec 2024 | tx 5+71,000 |
| Oncopeptides AB | 7,000 | net | 23 Aug 2021 | tx 4+7,000 |
| BioArctic AB | 1,500 | net | 16 Apr 2025 | tx 2+1,500 |
| Wilson Therapeutics | -1,400 | net | 25 May 2018 | tx 1−1,400 |
| Wilson Therapeutics AB | 1,400 | net | 07 Dec 2016 | tx 2+1,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Apr 2025 | PURCHASE | BioArctic AB | 500 | 164.70 SEK | |
| 20 Dec 2024 | PURCHASE | CANTARGIA AB | 25,000 | 1.85 SEK | |
| 12 Sept 2024 | PURCHASE | BioArctic AB | 1,000 | 172.00 SEK | first after silence |
| 27 Jul 2022 | PURCHASE | CANTARGIA AB | 20,000 | 3.75 SEK | |
| 06 Jul 2022 | PURCHASE | CANTARGIA AB | 6,000 | 7.02 SEK | |
| 23 Aug 2021 | PURCHASE | Oncopeptides AB | 2,000 | 41.18 SEK | |
| 26 May 2021 | PURCHASE | Oncopeptides AB | 2,000 | 102.09 SEK | |
| 29 Mar 2021 | PURCHASE | Oncopeptides AB | 1,000 | 137.62 SEK | first after silence |
| 02 Dec 2019 | PURCHASE | CANTARGIA AB | 8,000 | 17.10 SEK | |
| 26 Sept 2019 | PURCHASE | Oncopeptides AB | 2,000 | 119.18 SEK | first after silence |
| 25 May 2018 | SALE | Wilson Therapeutics | 1,400 | 232.00 SEK | |
| 07 Dec 2016 | PURCHASE | Wilson Therapeutics AB | 700 | 55.50 SEK | |
| 07 Dec 2016 | PURCHASE | Wilson Therapeutics AB | 700 | 55.75 SEK |
3 purchases reported after at least 12 months of silence — most recent on 12 Sept 2024.